To embed, copy and paste the code into your website or blog: On March 22, 2021, the U.S. Food and Drug Administration (FDA) issued warning letters to two companies, Honest Globe Inc. and Biolyte Laboratories LLC, for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). The warning letters specifically addressed the illegal marketing of unapproved drugs containing CBD intended for the treatment of pain relief. To date, the FDA has not approved any over-the-counter (OTC) drugs containing CBD and the FDA contends that none of the products cited in the warning letters meet the requirements to be legally marketed without an approved New Drug Application. The FDA's news release and warning letters can be found here.